1
Total investments
0
Early stage
0
Mid stage
0
Late stage
2y
Years active
Experience · 5 entries
All (5)
Investments (1)
Founder (4)
2024
Angel Investor and Healthcare Advisor
Mar 2024
SHACK15 Ventures provides funding and support for DeepTech and AI startups at the earliest stages: angel, pre-seed, and seed.
2022
2017
S
Sedna Genome, Inc.
CEO & Co-Founder
Aug 2017
2016
President & Co-Founder
Feb 2016
Proem Behavioral Health provides the premier clinical workflow software engine that helps behavioral health providers and research organizations efficiently and accurately screen, test, and measure treatment success for those suffering from mental illness. Proem is the exclusive digital licensee worldwide of gold-standard, evidence-based screening solutions, structured interviews, and post-diagnosis severity measurement scales to monitor patient outcomes. To learn more, visit www.proemhealth.com.
RESEARCH ORGANIZATIONS: Proem is the exclusive worldwide licensee of the digital versions of behavioral health tools that have been used by clinical and academic research organizations for over 25 years.
HEALTHCARE PROVIDERS: From behavioral health providers to pediatricians, the Proem solution makes it easy for healthcare providers to take action to improve their patients’ mental health.
SUBSTANCE USE DISORDER CLINICS: The Proem solution can help SUD Clinics identify and treat the underlying mental health conditions that lead to alcohol and substance use disorders.
2009
CEO & Co-Founder
Oct 2009
NudgeRx is a health care services company focused on filling the gaps in post-discharge follow-up care and improving patient adherence to treatment plans by providing patients and their designated family/friend caregivers with daily, interactive, recovery support for up to 90 days following their hospital discharge.
NudgeRx services are sold to health insurance companies who will include NudgeRx’s hospital discharge support as part of their plan member’s coverage. Approximately 20% of patients leaving the hospital experience an unplanned readmission within 30 days of discharge. Nationwide, unplanned readmissions are estimated to cost over $56B annually, of which $39B is judged to be preventable. NudgeRx believes that it can significantly reduce these costs by improving patient adherence to discharge plans and by identifying potential problems before they become acute.
